Clinical Trial Update: Evaluation of Rebamipide and Rabeprazole Effect Associated or Not to Prevent Naproxen-induced Gastric Lesions [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated Rebamipide with or without Rabeprazole for prevention of naproxen-induced gastric lesions; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Lesion

Drugs mentioned

• Naproxen (Naproxen)
• Rabeprazole (rabeprazole)
• Rebamipide (rebamipide)

Snippet

Sponsor: Galeno Desenvolvimento de Pesquisas Clínicas | Conditions: Gastric Lesion | Phase 3 | Status: COMPLETED